FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely oncology, and can be used to treat locally common malignant neoplasms of the nasopharynx. Before chemoradiotherapy, superselective X-ray endovascular chemoembolization of tumor vessels is performed using HepaSphere microspheres saturated with doxorubicin. 21 days after superselective chemoembolization, adjuvant conformal remote radiotherapy is performed simultaneously on the nasopharyngeal tumor area at a total focal dose of 66-70 Gy and a single focal dose of 2 Gy in combination with chemotherapy with cisplatin at a dose of 75 mg /m2 and 5-fluorouracil at a dose of 750 mg /m2.
EFFECT: method provides reduction in traumatism, morbidity, the share of absolute contraindications to radiation therapy and the proportion of degree 3 to 5 complications, an increase in overall and relapse-free survival, quality of life and local control over the tumor process by performing superselective X-ray endovascular chemoembolization of tumor vessels using microspheres saturated with an antitumor drug.
1 cl, 4 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CERVICAL CANCER USING CHEMOEMBOLISATION OF UTERINE ARTERIES WITH PLATINUM DRUGS | 2015 |
|
RU2583144C1 |
METHOD OF RADIATION THERAPY OF LOCALLY ADVANCED CERVICAL CANCER | 2019 |
|
RU2719902C1 |
METHOD OF ENDOVASCULAR THERAPY OF LOCALLY ADVANCED RECTAL CANCER COMPLICATED BY COLONIC OBSTRUCTION | 2011 |
|
RU2469658C2 |
METHOD OF TREATMENT OF INOPERABLE SQUAMOUS CELL CARCINOMA OF HEAD AND NECK | 2023 |
|
RU2806512C1 |
METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED MALIGNANT TUMORS OF CERVICAL ESOPHAGUS AND HYDROPHARYNTHAS | 2022 |
|
RU2786832C1 |
METHOD FOR PREOPERATIVE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER AT T1b2-T2b STAGE | 2016 |
|
RU2613888C1 |
METHOD OF TREATING LOCALLY ADVANCED MALIGNANT GROWTHS OF ORAL CAVITY AND OROPHARYNX | 2018 |
|
RU2709549C1 |
METHOD OF TREATING RECURRENT NASOPHARYNX CANCER | 2009 |
|
RU2420333C2 |
METHOD FOR TREATMENT OF SQUAMOUS CELL P-16 POSITIVE OROPHARYNGEAL CANCER | 2020 |
|
RU2751818C2 |
METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED FORMS OF CERVICAL CANCER IIB-IIIB (T2B-T3BN0(1)M0) STAGES | 2020 |
|
RU2748135C2 |
Authors
Dates
2021-12-16—Published
2021-02-17—Filed